Fresenius SE KGaA (XTER:FRE) Debt-to-Equity : 0.83 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Debt-to-Equity?

Fresenius SE KGaA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €2,581 Mil. Fresenius SE KGaA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €13,249 Mil. Fresenius SE KGaA's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €18,999 Mil. Fresenius SE KGaA's debt to equity for the quarter that ended in Dec. 2023 was 0.83.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fresenius SE KGaA's Debt-to-Equity or its related term are showing as below:

XTER:FRE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.83 Med: 1.38 Max: 1.64
Current: 0.83

During the past 13 years, the highest Debt-to-Equity Ratio of Fresenius SE KGaA was 1.64. The lowest was 0.83. And the median was 1.38.

XTER:FRE's Debt-to-Equity is ranked worse than
67.52% of 548 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs XTER:FRE: 0.83

Fresenius SE KGaA Debt-to-Equity Historical Data

The historical data trend for Fresenius SE KGaA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Debt-to-Equity Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.63

1.53

1.43

1.36

0.83

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															1.36	1.35	1.40	0.76	0.83

Competitive Comparison of Fresenius SE KGaA's Debt-to-Equity

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius SE KGaA's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Debt-to-Equity falls into.

Fresenius SE KGaA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fresenius SE KGaA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2581	+	13249)	/	18999
	=	0.83

Fresenius SE KGaA's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2581	+	13249)	/	18999
	=	0.83

Fresenius SE KGaA (XTER:FRE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fresenius SE KGaA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (XTER:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Executives

Dr. Michael Moser	Board of Directors
Sara Hennicken	Board of Directors
Michael Sen	Board of Directors
Dr. Francesco De Meo	Board of Directors
Stephan Sturm	Board of Directors
Wolfgang Kirsch	Supervisory Board
Mats Henriksson	Board of Directors
Dr. Gerd Krick	Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines